How to Bring Pharma to Market by Mastering Brand, Story, and Value | Nara Daubeney скачать в хорошем качестве

How to Bring Pharma to Market by Mastering Brand, Story, and Value | Nara Daubeney

Follow Bill:   / founderandcdo   Contact Bill: https://meshagency.com/lets-connect/ Video Podcast:    / @billschickfcmo   Audio Podcast: https://www.buzzsprout.com/2380430 Contact Nara Daubeney:   / nara-daubeney   _______________________________ Timestamps: 00:00 Intro 01:31 About Nara Daubeney PhD 04:25 Nara Daubeney’s Motivation 06:35 Demonstrating Value & Phaim Pharma 09:07 Start-up Founders Biggest Mistake 09:44 Nara Daubeney’s Philosophy 09:59 How to Communicate the Value of Your Life Science Company 12:08 How to Empathize with your Customer & Stakeholders 13:53 Identifying Your Target Audience 14:29 Example of Effective Messaging 15:45 Why Websites are Valuable for Life Science Companies 22:25 LinkedIn for Life Science Founders 25:58 Common Life Science Company Positioning and Messaging Mistakes 26:45 Leading with Authenticity in Life Sciences 29:23 Lessons for Life Science Marketing _______________________________ Bringing a brand-new autoimmune therapy to market can feel overwhelmingly complex—especially when you’re juggling scientific rigor, regulatory hurdles, and investor skepticism. Many life science founders struggle to communicate the true value of their innovation, leaving them overlooked in a saturated marketplace. Imagine finally developing a game-changing treatment only to watch stakeholders shrug because they don’t fully grasp your therapeutic’s transformative potential. Or think about the uphill battle of securing funding when investors can’t see why your product stands out from the rest. Without a clear, compelling brand story and patient-centered messaging, brilliant solutions stay buried. In this episode of LifeSci Continuum, I speak with Dr. Nara Daubeney—CEO & Co-Founder of Phaim Pharma, surgeon, and biotech executive—about her journey in launching a new autoimmune therapy. She reveals how thoughtful storytelling, audience-focused messaging, and transparent value propositions can attract the right partners and propel clinical success. From leveraging LinkedIn as a personal brand amplifier to crafting a website that educates and captivates, Dr. Daubeney shares actionable tips for life science entrepreneurs aiming to transform great ideas into real-world therapies. For those tackling this on their own, consider these tips: 1. Many life science founders focus solely on product development during the early stages, neglecting the power of brand co-creation with their earliest customers. Identify a select group of early adopters—clinicians, researchers, or key opinion leaders—who not only test your solution but also help shape your brand’s narrative. By involving them in refining your brand message, you ensure it resonates with the real-world challenges and aspirations of your target audience. Their buy-in becomes a powerful form of social proof, showcasing authentic advocacy that sets you apart in a crowded marketplace. 2. Embed Scientific Rigor into Every Brand Touchpoint Pro Tip: Consistently Translate Complex Data into Clear, Insightful Narratives. In a field where trust hinges on evidence, your brand must radiate credibility at every turn—yet many life science teams only emphasize data in white papers or scientific conferences. Instead, weave simplified but accurate data-driven insights into marketing materials, pitch decks, and website copy. Showcase the logical progression from early research to proof of concept, then clinical results, explaining why your approach is not just novel but superior. This builds a brand identity that stands for robust science rather than shallow hype—an invaluable differentiator in an industry saturated with lofty claims. 3. Design Your Brand for Scalability from Day One Pro Tip: Establish a Modular Framework That Adapts to New Markets and Indications. Most early-stage founders think about branding as static—a logo, color palette, and tagline—without considering the future expansions of their pipeline. Instead, build a flexible brand architecture that accommodates new drug candidates, therapeutic areas, or clinical indications. Incorporate naming systems, color variations, and messaging frameworks that can pivot seamlessly as your portfolio grows. This foresight prevents brand fragmentation down the road and allows you to maintain relevance, even as you enter new markets or pivot to different applications of your core science. For more specialized help with growth, check out my firm, Mesh. https://meshagency.com/ #LifeSciences #HealthcareInnovation #ProductMarketing